Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|18|2|163-169
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.2, 2018-02, pp. : 163-169
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Kivircik B.B. Alptekin K. Caliskan S. Comlekci A. Oruk G. Tumuklu M. Kurklu K. Arkar H. Turk A. Caliskan M. Yesil S.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. :
Access to resources
Recommend
QOL assessment tailored to patients with schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
By Katsiki Niki Mikhailidis Dimitri P Gotzamani-Psarrakou Anna Yovos John G Karamitsos Dimitrios
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 4, 2011-04 ,pp. :